Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Radiat Res ; 197(1): 43-56, 2022 01 01.
Article in English | MEDLINE | ID: mdl-33857285

ABSTRACT

Experimental mouse studies are important to gain a comprehensive, quantitative and mechanistic understanding of the biological factors that modify individual risk of radiation-induced health effects, including age at exposure, dose, dose rate, organ/tissue specificity and genetic factors. In this study, neonatal Ptch1+/- mice bred on CD1 and C57Bl/6 background received whole-body irradiation at postnatal day 2. This time point represents a critical phase in the development of the eye lens, cerebellum and dentate gyrus (DG), when they are also particularly susceptible to radiation effects. Irradiation was performed with γ rays (60Co) at doses of 0.5, 1 and 2 Gy, delivered at 0.3 Gy/min or 0.063 Gy/min. Wild-type and mutant mice were monitored for survival, lens opacity, medulloblastoma (MB) and neurogenesis defects. We identified an inverse genetic background-driven relationship between the radiosensitivity to induction of lens opacity and MB and that to neurogenesis deficit in Ptch1+/- mutants. In fact, high incidence of radiation-induced cataract and MB were observed in Ptch1+/-/CD1 mutants that instead showed no consequence of radiation exposure on neurogenesis. On the contrary, no induction of radiogenic cataract and MB was reported in Ptch1+/-/C57Bl/6 mice that were instead susceptible to induction of neurogenesis defects. Compared to Ptch1+/-/CD1, the cerebellum of Ptch1+/-/C57Bl/6 mice showed increased radiosensitivity to apoptosis, suggesting that differences in processing radiation-induced DNA damage may underlie the opposite strain-related radiosensitivity to cancer and non-cancer pathologies. Altogether, our results showed lack of dose-rate-related effects and marked influence of genetic background on the radiosensitivity of Ptch1+/-mice, supporting a major contribution of individual sensitivity to radiation risk in the population.


Subject(s)
Medulloblastoma/ethnology , Neoplasms, Radiation-Induced/etiology , Animals , Dose-Response Relationship, Radiation , Gamma Rays , Genetic Background , Humans , Lens, Crystalline/radiation effects , Mice, Inbred C57BL , Neurogenesis , Radiation Tolerance , Whole-Body Irradiation
2.
Radiat Res ; 197(1): 22-35, 2022 01 01.
Article in English | MEDLINE | ID: mdl-33857324

ABSTRACT

One harmful long-term effect of ionizing radiation is cataract development. Recent studies have been focused on elucidating the mechanistic pathways involved in this pathogenesis. Since accumulating evidence has established a role of microRNAs in ocular diseases, including cataract, the goal of this work was to determine the microRNA signature of the mouse lens, at short time periods postirradiation, to understand the mechanisms related to radio-induced cataractogenesis. To evaluate the differences in the microRNA profiles, 10-week-old Patched1 heterozygous (Ptch1+/-) mice, bred onto two different genetic backgrounds (CD1 and C57Bl/6J), received whole-body 2 Gy γ-ray irradiation, and 24 h later lenses were collected. Next-generation sequencing and bioinformatics analysis revealed that genetic background markedly influenced the list of the deregulated microRNAs and the mainly predicted perturbed biological functions of 2 Gy irradiated Ptch1+/- mouse lenses. We identified a subset of microRNAs with a contra-regulated expression between strains, with a key role in regulating Toll-like receptor (TLR)-signaling pathways. Furthermore, a detailed analysis of miRNome data showed a completely different DNA damage response in mouse lenses 24 h postirradiation, mainly mediated by a marked upregulation of p53 signaling in Ptch1+/-/C57Bl/6J lenses that was not detected on a CD1 background. We propose a strict interplay between p53 and TLR signaling in Ptch1+/-/C57Bl/6J lenses shortly after irradiation that could explain both the resistance of this strain to developing lens opacities and the susceptibility of CD1 background to radiation-induced cataractogenesis through activation of epithelial-mesenchymal transition.


Subject(s)
Cataract/etiology , Lens, Crystalline/radiation effects , Animals , DNA Damage/radiation effects , Disease Models, Animal , Dose-Response Relationship, Radiation , Gamma Rays , Genetic Background , Humans , Mice, Inbred C57BL , MicroRNAs , Patched-1 Receptor/metabolism , Signal Transduction , Toll-Like Receptors/metabolism , Whole-Body Irradiation
3.
DNA Repair (Amst) ; 74: 70-79, 2019 02.
Article in English | MEDLINE | ID: mdl-30606609

ABSTRACT

DSBs are harmful lesions produced through endogenous metabolism or by exogenous agents such as ionizing radiation, that can trigger genomic rearrangements. We have recently shown that exposure to 2 Gy of X-rays has opposite effects on the induction of Shh-dependent MB in NHEJ- and HR-deficient Ptch1+/- mice. In the current study we provide a comprehensive link on the role of HR/NHEJ at low doses (0.042 and 0.25 Gy) from the early molecular changes through DNA damage processing, up to the late consequences of their inactivation on tumorigenesis. Our data indicate a prominent role for HR in genome stability, by preventing spontaneous and radiation-induced oncogenic damage in neural precursors of the cerebellum, the cell of origin of MB. Instead, loss of DNA-PKcs function increased DSBs and apoptosis in neural precursors of the developing cerebellum, leading to killing of tumor initiating cells, and suppression of MB tumorigenesis in DNA-PKcs-/-/Ptch1+/- mice. Pathway analysis demonstrates that DNA-PKcs genetic inactivation confers a remarkable radiation hypersensitivity, as even extremely low radiation doses may deregulate many DDR genes, also triggering p53 pathway activation and cell cycle arrest. Finally, by showing that DNA-PKcs inhibition by NU7441 radiosensitizes human MB cells, our in vitro findings suggest the inclusion of MB in the list of tumors beneficiating from the combination of radiotherapy and DNA-PKcs targeting, holding promise for clinical translation.


Subject(s)
Cerebellar Neoplasms/genetics , DNA Repair/radiation effects , Medulloblastoma/genetics , Neoplasms, Radiation-Induced/genetics , Patched-1 Receptor/deficiency , Patched-1 Receptor/metabolism , Animals , Carcinogenesis/genetics , Carcinogenesis/radiation effects , Cell Line, Tumor , Cerebellar Neoplasms/metabolism , Cerebellar Neoplasms/pathology , Cerebellar Neoplasms/therapy , DNA Damage , DNA End-Joining Repair/radiation effects , DNA Helicases/genetics , DNA-Activated Protein Kinase/deficiency , DNA-Binding Proteins/deficiency , Dose-Response Relationship, Radiation , Homologous Recombination/radiation effects , Humans , Medulloblastoma/metabolism , Medulloblastoma/pathology , Medulloblastoma/therapy , Mice , Molecular Targeted Therapy , Mutation , Neoplasms, Radiation-Induced/metabolism , Neoplasms, Radiation-Induced/pathology , Neoplasms, Radiation-Induced/therapy , Nuclear Proteins/deficiency , Nuclear Proteins/genetics , Risk , X-Rays/adverse effects
5.
J Neurochem ; 79(3): 531-8, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11701756

ABSTRACT

Calcineurin is a serine/threonine phosphatase involved in a wide range of cellular responses to calcium mobilizing signals. Previous evidence supports the notion of the existence of a redox regulation of this enzyme, which might be relevant for neurodegenerative processes, where an imbalance between generation and removal of reactive oxygen species could occur. In a recent work, we have observed that calcineurin activity is depressed in two models for familial amyotrophic lateral sclerosis (FALS) associated with mutations of the antioxidant enzyme Cu,Zn superoxide dismutase (SOD1), namely in neuroblastoma cells expressing either SOD1 mutant G93A or mutant H46R and in brain areas from G93A transgenic mice. In this work we report that while wild-type SOD1 has a protective effect, calcineurin is oxidatively inactivated by mutant SOD1s in vitro; this inactivation is mediated by reactive oxygen species and can be reverted by addition of reducing agents. Furthermore, we show that calcineurin is sensitive to oxidation only when it is in an 'open', calcium-activated conformation, and that G93A-SOD1 must have its redox-active copper site available to substrates in order to exert its pro-oxidant properties on calcineurin. These findings demonstrate that both wild-type and mutant SOD1s can interfere directly with calcineurin activity and further support the possibility of a relevant role for calcineurin-regulated biochemical pathways in the pathogenesis of FALS.


Subject(s)
Amyotrophic Lateral Sclerosis/metabolism , Calcineurin/metabolism , Dithiothreitol/analogs & derivatives , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Aerobiosis , Amyotrophic Lateral Sclerosis/genetics , Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Calcium/metabolism , Copper/metabolism , Dithiothreitol/pharmacology , Enzyme Activation/drug effects , Enzyme Activation/physiology , Humans , Nerve Degeneration/genetics , Nerve Degeneration/metabolism , Oxidation-Reduction , Point Mutation , Reactive Oxygen Species/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
8.
J Neurochem ; 75(2): 606-13, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10899935

ABSTRACT

Calcineurin (CN) is a protein phosphatase involved in a wide range of cellular responses to calcium-mobilizing signals, and a role for this enzyme in neuropathology has been postulated. We have investigated the possibility that redox modulation of CN activity is relevant to neuropathological conditions where an imbalance in reactive oxygen species has been described. We have monitored CN activity in cultured human neuroblastoma SH-SY5Y cells and obtained evidence that CN activity is promoted by treatment with ascorbate or dithiothreitol and impaired by oxidative stress. Evidence for the existence of a redox regulation of this enzyme has been also obtained by overexpression of wild-type antioxidant Cu,Zn superoxide dismutase (SOD1) that promotes CN activity and protects it from oxidative inactivation. On the contrary, overexpression of mutant SOD1s associated with familial amyotrophic lateral sclerosis (FALS) impairs CN activity both in transfected human neuroblastoma cell lines and in the motor cortex of brain from FALS-transgenic mice. These data suggest that CN might be a target in the pathogenesis of SOD1-linked FALS.


Subject(s)
Calcineurin/metabolism , Motor Neuron Disease/enzymology , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Animals , Ascorbic Acid/pharmacology , Calcium/metabolism , Dithiothreitol/pharmacology , Hippocampus/metabolism , Humans , Mice , Mice, Transgenic , Motor Cortex/metabolism , Motor Neuron Disease/genetics , Neuroblastoma , Oxidation-Reduction , Oxidative Stress , Recombinant Proteins/metabolism , Spinal Cord/metabolism , Transfection , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...